Apelin, a regulator of insulin sensitivity [104], has demonstrated protective effects in diabetic retinopathy [111], while galectin-3 has been identified as a key factor in fibrosis and inflammatory responses [118], particularly in nephropathy and neuropathy [115,116,117]. Here, LGALS3 is linked to diabetic retinopathy.